Abstract: Antimicrobial resistance (AMR) is a global health threat, and a standstill in the discovery and design of new antibiotics has been linked to the growing number of human deaths attributed to AMR infections. Intensive beef production utilizes antimicrobials to promote health and growth efficiency. To understand the magnitude and risk of AMR in beef production, it is important to assess the prevalence and diversity of antimicrobial resistant genes (ARGs) within microbial populations. Antimicrobial resistant bacteria are traditionally identified by isolation and growth in the presence of selective antibiotics. Whole-genome, metagenomic, and RNA sequencing provide new avenues to detect and identify novel ARGs in both culturable and unculturable bacterial communities. Some of these approaches place ARGs within the context of mobile genetic elements, gauging their likelihood of transfer across genomes. Genomics can also mitigate AMR, contributing to rational drug design or the development of alternatives to antimicrobials such as vaccines and probiotics. RNA-seq-based transcriptomics and Tn-seq may provide new ways to examine mechanisms that promote or prevent AMR. Finally, clustered regularly interspaced short palindromic repeats (CRISPR) -Cas gene editing could directly reduce AMR by killing AMR-resistant bacteria without harming beneficial bacteria. Together, these technologies may provide new opportunities to identify, quantify, and mitigate AMR while developing alternatives to antimicrobials for beef production.
Antimicrobial Resistance and Usage in Beef Cattle
The discovery of antibiotics (antimicrobials) was one of the most significant developments in contemporary science. Prior to the 1940s, infectious disease was the predominant cause of human death (Jones et al. 2012 ). In the current era of antimicrobial therapy, the majority of bacterial infections in both humans and animals can be successfully treated. Despite this, the effectiveness of antimicrobial therapy is threatened by the emergence of antimicrobial resistant (AMR) bacteria and constrained by the limited number of new and novel antimicrobials in the discovery pipeline.
AMR is a global concern for both human and veterinary medicine. The use of antimicrobials in livestock production is contentious because of the potential for the genesis and transmission of antimicrobial resistant genes (ARGs) between veterinary pathogens and zoonotic pathogens that may threaten humans. Resistance to multiple antimicrobial families is a serious issue, with highly mobile genetic elements (MGEs) that contain a number of ARGs of particular concern. In general, the presence of AMR is best studied in clinically important microbes from hospitals, veterinary medicine, and food samples. However, ARGs can be carried by nonpathogenic or environmental bacteria that may serve as reservoirs of these genes that can be acquired by pathogens. The total ARG repertoire of any microbial population is termed the resistome. Knowledge of the resistome may aid in the development of strategies to mitigate AMR on a broader scale and at higher, managerial levels of animal production.
Globally, ∼80% of antimicrobials manufactured are given to livestock (Huttner et al. 2013 ). This reflects both the size of animal populations in production systems as well as the mass of individual animals and the antimicrobial use (AMU) needed to maintain animal health in large, confined feeding operations. For beef production, antimicrobials are used for disease prevention, therapy, and to improve animal growth and feed efficiencies. In-feed antimicrobials can reduce feed requirements and increase weight gains by 2%-15%, enhancing on-farm profitability (Hao et al. 2014) . Respiratory pneumonia, foot rot, hepatic abscesses, and ruminal acidosis are some of the most frequent diseases in cattle that necessitate AMU. Prevention or resolution of these infections/diseases relies on effective antimicrobials. Consequently, safeguarding antimicrobial efficacy is critical to sustain animal health and profitability in beef production.
Unless there are changes in conventional practises, AMU in livestock and poultry production is predicted to rise ∼67% by 2030 (Van Boeckel et al. 2015) . As a result, enhanced AMR surveillance will be increasingly important to evaluate specific risks associated with AMU and to identify intervention strategies that mitigate the dissemination and long-term enrichment of ARGs. This review highlights recent genomic advances that have opened new avenues to investigate the abundance and function of ARGs and also presents ways that these technologies can be used to mitigate AMR through the development of alternatives to antimicrobials for use in beef production.
Genomics-based Technologies with Relevance to AMR
Culture-based resistance profiling
Conventional AMR detection employs culture-based, phenotypic assays for antimicrobial sensitivity testing (AST). These approaches determine the presence and degree of AMR in culturable bacteria. Culture-based assays are limited in that they do not provide information about the genetic mechanism of resistance, and only through the use of genomic techniques such as polymerase chain reaction (PCR) and whole genome sequencing (WGS), can the ARGs conferring resistance be identified and linked to phenotype (Chantziaras et al. 2014) . However, DNA sequence-based gene detection methodologies do not provide information on the level of resistance as they do not confirm if ARGs are expressed or the functionality of translated proteins. As bacterial strains can harbor inactive ARGs (Davis et al. 2011 ), AST will likely remain an important tool for the characterization of AMR in both agricultural and hospital environments. However, developments in high-throughput nucleic acid sequencing technologies, as described in the following section, should enable ARGs in bacteria to be rapidly characterized in an increasingly cost-effective manner in both chute and bed-side settings. As a result, we will likely see the widespread adoption of genomics-based AMR detection tools in both veterinary and medical diagnostics in the near future.
High-throughput DNA sequencing
Over the last two decades, there has been a rapid development of high-throughput or "next"-or "second"-generation sequencing (NGS) platforms and associated bioinformatic software (Köser et al. 2014) . Various platforms exist for short-read, single-molecule real-time long-read, and synthetic long-read technologies, each varying with regard to cost, error rates, and read structure (Goodwin et al. 2016) . Although the requirements of each study will determine the most relevant platform to use, the Illumina system currently holds the largest market share of available platforms (Goodwin et al. 2016) . The majority of sequence data published is available for public use via central biotechnology databases including the National Center for Biotechnology Information (NCBI; https://www.ncbi.nlm.nih.gov/), the European Molecular Biology Laboratory (EMBL; http:// www.embl.de), and the DNA Data Bank of Japan (DDBJ; http://www.ddbj.nig.ac.jp).
Advances in sequencing technologies and analysis tools have given rise to the "omics" science areas including genomics (DNA), transcriptomics (mRNA), proteomics (peptides and proteins), and inferred metabolomics (metabolites). Together these tools can be used in a high-throughput manner for comprehensive surveillance and characterization of AMR prevalence and development and in devising AMR mitigation strategies. Some of the linkages among these approaches are illustrated in Fig. 1 , with examples of their applications in the context of AMR investigations.
Whole-genome sequencing and comparative genomics
Whole-genome sequencing can be applied to AMR research through the identification of AMR strains, monitoring the evolution and transmission of AMR bacterial pathogens, facilitating the development of improved diagnostic screening for ARGs, and through identification of novel antimicrobials and their targets (Punina et al. 2015) . Specialty databases such as the Antibiotic Resistance Genes Database (Liu and Pop 2009) (Zankari et al. 2012) , antibiotic resistance geneannotation (ARG-annot; Gupta et al. 2014) , and MEGARes (Lakin et al. 2017) are useful tools to screen both whole-and meta-genomic sequence data for previously identified ARGs. In addition, associations of ARGs with MGEs including plasmids, transposons, prophage, and integrative conjugative elements (Hegstad et al. 2010) can be characterized through WGS. Frequently, the lower guanine-cytosine (GC) content of these regions aides in their identification within host genomes (Boyd et al. 2001; Sebaihia et al. 2006; Hayek 2013) . Genes required for the mobility and (or) integration of mobile elements, including integrases and transfer genes provide context, potentially indicating sequences that may also contain ARGs (Sebaihia et al. 2006) . Multicopy plasmids are also observable within sequence information with the observed read coverage related to plasmid copy number. Recently, WGS was used to identify eight novel plasmids carrying ARGs to aminoglycosides, carbapenems, penicillins, cephalosporins, chloramphenicol, dihydrofolate reductase inhibitors, sulfonamides, and tetracyclines as well as resistance to heavy metals in Shiga toxin-producing and generic Escherichia coli strains isolated from animals and humans (Losada et al. 2016) . Fig. 1 . Genomic approaches for characterizing and mitigating antimicrobial resistance (AMR). A modern arsenal of complementary sequence-based technologies enables precision omics-based analyses of both cultured and uncultured (metagenomic) bacterial samples. Genomics-based analyses have a multitude of uses, including (i) the detection, identification, and characterization of antimicrobial resistance genes (ARGs), mobile genetic elements (MGEs), and drug-resistant pathogens, (ii) the design of diagnostics, including for AMR surveillance and for monitoring the transmission of AMR pathogens and ARGs, and (iii) discovery of new antimicrobials and nonantimicrobial approaches to pathogen control. Figure appears in colour on the Web.
The presence of plasmids in the strains was identified by the evidence of circularity as determined by mate-pair read status, difference in read depth, and annotations and sequence similarity associated with other plasmids. Whole-genome sequencing confirmed horizontal gene transfer of the methicillin resistance gene mecA from Staphylococcus epidermidis to Staphylococcus aureus (Bloemendaal et al. 2010) .
Comparative genomics can further aid in the identification of previously unknown ARGs by highlighting differing genomic sequences among resistant and sensitive bacterial isolates. BLAST-based sequence alignments to the ARG databases described above can potentially detect previously identified ARG homologs and variants in strain-specific DNA. This strategy was used to identify putative ARGs in species of Clostridium difficile, with some of the predicted genes supported by experimental data, whereas others were not (Sebaihia et al. 2006) . The use of WGS data to predict resistance phenotype has also been employed with over 95% confidence in S. aureus (MRSA) (Gordon et al. 2014 ), E. coli, Klebsiella pneumonia (Stoesser et al. 2013) , C. difficile (Eyre et al. 2012) , and Pseudomonas aeruginosa (Kos et al. 2015) . Advancements in bioinformatics analyses will likely result in WGS becoming the standardized tool for the detection of AMR bacterial strains within clinical settings (Punina et al. 2015) . Comparative genomics has also been used to study AMR in bacteria isolated from beef cattle. For example, MGEs known as integrative and conjugative elements (ICE) were identified in strains of Mannheimia haemolytica originating from cases of bovine respiratory disease (BRD) (Klima et al. 2016) . Some of the ICE harbored extensive multidrug resistance cassettes carrying up to 11 AMR genes directly threatening the efficacy of veterinary antimicrobial therapies used to treat respiratory infections in cattle (Klima et al. 2016) . Similarly, NGS and comparative genomics of four broad-host-range incompatibility group A/C (IncA/C) plasmids extracted from E. coli demonstrated that this MGE was responsible for encoding resistance to florfenicol, tetracycline, and extended spectrum β-lactams in isolates from dairy cows, pigs, and turkeys in the USA and Chile (Fernández-Alarcón et al. 2011) .
Whole-genome sequencing and comparative genomics are also useful for assessing the mobility, transfer, and dissemination of ARGs within bacteria associated with beef cattle and their surrounding environment. Previously, pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were the primary tools for source tracking of AMR bacteria. The ever-decreasing cost of sequencing, coupled with the increasing availability of tools to support data handling, is leading to WGS becoming a primary tool for studying the epidemiology of ARGs. For example, WGS has been used to examine the transfer of ARG containing bacteria between animals and humans. A longitudinal study utilizing WGS showed that MDR Salmonella enterica subsp.
Typhimurium infections in humans were not linked to transmission from animals and the phylogenetic relationships both within and between the resistance determinants and host bacteria differed (Mather et al. 2013 ). However, recent work using MLST and WGS suggests that livestock-associated methicillin-resistant S. aureus (MRSA) CC398 originated from methicillin-susceptible S. aureus in humans (Price et al. 2012) , whereas a separate study linked MSRA strains in humans carrying mecC to a livestock reservoir (Harrison et al. 2013) . These studies highlight the movement of bacteria, and the ARGs they contain from and amongst human and animal sources, and point to the role WGS will likely play as a future tool to better characterize the transmission of AMR.
Currently, the largest barriers toward the widespread application of WGS in AMR beef cattle research lie in the cost. However, as sequencing technologies continue to evolve, costs are expected to continue to plummet, outstripping Moore's Law to the point where in the next 10 yr, analyzing the abundance of sequence data will be the rate limiting step in AMR science. Research will likely focus on the expansion of the bioinformatic tools that will enable those that are not specialized in bioinformatics and computer programing to analyze and interpret these data. However, as sequence databases continue to grow and specialty AMR databases expand, WGS will become increasingly important to AMR surveillance in both hospital and livestock production settings.
Metagenomic sequencing
Although WGS applications typically examine individual bacterial strains, metagenomics examines DNA extracted from an entire microbial community. Metagenomic sequencing, in combination with data analysis tools such as MG-RAST (Metagenomics Rapid Annotation using Subsystem Technology; Meyer et al. 2008 ) provides information on all known genes within a sample and allows for the examination of a community of genes based on their function. Three types of metagenomics studies are commonly conducted: (1) single/ marker-gene amplicon sequencing studies (e.g., 16s rRNA genes), (2) shotgun, or whole metagenomics sequencing, and (3) environmental clone libraries (functional metagenomics). Although 16S rRNA gene sequencing has been widely used to predict the structure of microbial communities using bioinformatic software packages such as PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States; Langille et al. 2013) , it does not generate information on the ARGs within a bacterial population. In contrast, whole metagenomics sequencing provides thorough genetic information of microbial communities, describing their complete genetic potential, including the prevalence of ARGs and their genetic variation.
Although this technique may be used to identify known ARGs, it usually lacks the ability to link ARGs to specific bacterial species (D'Costa et al. 2006), unless samples are sequenced to a depth that enables bacterial genomes to be assembled. Despite this, metagenomics is an efficient way to survey the resistome in animal production environments. Composite samples collected from the digestive tract, animal tissues, feces, and the surrounding environment are particularly useful for using metagenomics to detect ARGs throughout livestock production systems. For example, sequencing the rumen microbial populations in Indian buffalo and the fecal populations of cattle revealed that only 6.4% and 8.4%, respectively, of the sequence data coded for virulence traits or ARGs (Durso et al. 2011; Singh et al. 2012) . Metagenomic sequencing and analysis of ARGs in dairy cow feces after therapeutic administration of a thirdgeneration cephalosporin revealed an increase in sequences associated with resistance to β-lactams and multidrug resistance within 3 d after treatment (Chambers et al. 2015) . Metagenomics of pig, chicken, and human fecal microbial communities also detected ARGs conferring tetracycline, erythromycin, and aminoglycoside resistance, indicating that bacteria from chickens harbored the greatest ARGs and associated MGEs (Ma et al. 2016) .
Metagenomics may also be used to evaluate the risks associated with AMR in the food chain. For example, the resistomes of manure, soil, and wastewater from dairy and beef production systems were examined by aligning shotgun metagenomic reads to a custom nonredundant database of ARGs sequences compiled from ARG databases: ARG-ANNOT, Resfinder, and CARD (Noyes et al. 2016) . The majority of resistance-associated sequences coded for tetracycline resistance (Noyes et al. 2016) . Samples taken on ranches contained fewer ARGs than dairy or feedlot samples. Of interest, the resistome associated with dairy operations differed from beef cattle feedlots (Noyes et al. 2016) . A similar type of analysis applied to samples collected from environments impacted by livestock and municipal waste showed that the overall abundance of ARGs in human, cattle, and swine waste streams was similar (Agga et al. 2015) . However, human waste discharged from municipal wastewater treatment plants contained more ARG diversity compared with waste from livestock environments (Agga et al. 2015) . Elsewhere, comparisons of fecal DNA isolated from swine reared with in-feed antimicrobials (chlortetracycline, sulfamethazine, and penicillin), or without antimicrobials, showed that antimicrobials selected for AMR microbes (Looft et al. 2012) . Furthermore, coselection for aminoglycoside resistance was evident, despite the fact that aminoglycoside was not included in feed (Looft et al. 2012) .
Studies examining the effects of AMU on the abundance and diversity of ARGs in livestock systems aid in evaluating the risks of AMU in food production. Despite this, it is important to note that metagenomic analyses do not directly determine if the presence of an ARG contributes to phenotypic resistance. Metagenomic sequence analysis is almost entirely limited to the identification of known ARGs or close variants. Thus, identification of novel ARGs can be difficult, and the genomic context in terms of linkages or association with MGE of those ARGs identified may not be discernible if assembly scaffolds are not large enough. Recent advancement in the generation of long sequence reads via the highthroughput Illumina TruSeq long-read hybrid subassembly technology (White et al. 2016 ) may be helpful in resolving this issue as assemblies using this technology have resulted in more than 10,000 contigs over 10 kbp in length and have successfully assembled complete genomes from complex soil metagenomes.
Metagenomics is likely to be an important tool for the investigation of AMR in beef cattle research in the future. As long-read technologies advance, resulting in more robust assemblies and (or) completed genomes from metagenomic samples, it is possible that metagenomics could replace much of the culture-based work used to survey AMR in the feedlot environment. Efforts will need to be directed toward improving and building on the curated AMR databases used to identify ARGs from veterinary samples. Currently, there is a strong bias in these toward clinically derived ARGs. As with all of the genomic-based technologies, as the cost of sequencing goes down, there will be the need to develop more efficient and user friendly analytical pipelines to manage the large data sets produced.
Nucleic acid hybridization-based pull-down approaches
Although metagenomic sequencing provides the capacity to generate sequence data from entire communities, there are some cases in which information from only specific types of sequences (i.e., ARGs) is required and the additional sequence data obtained results in unnecessary computational burden. In these circumstances, a hybridization-based bait pull-down approach, often referred to as target enrichment or target capture, can be applied to selectively screen samples prior to sequencing. In this strategy, custom sequence captures probes, either in an array or solution target sequences of interest. In the array method, microarrays containing probes complimentary to the regions of interest are used to bind and purify DNA (Bodi et al. 2013 ). In the solutionbased method, biotinylated DNA or RNA baits are used to bind targets that are then purified using streptavidin-labelled magnetic beads (Bodi et al. 2013) . Ultimately, target enrichment provides advantages when sequence data unrelated to the topic of interest only increase cost and the complexity of bioinformatic analyses.
As with most hybridization-based assays, pull-down approaches necessitate prior knowledge of the DNA sequence of interest for probe design. Thus, this strategy cannot be used to enrich for novel ARGs but can concentrate known DNA sequences (e.g., low abundance ARGs and ARG variants). This technique can also purify DNA from samples in which amplification or sequencing is hindered by inhibitors, such as the humates found in soil (Yankson and Steck 2009) . Pull-down techniques can also be used for studying ARG expression when mRNA is isolated from the samples. For example, an mRNA solution-based pull-down assay was developed for detection of extended-spectrum β-lactamases (ESBL) bla OXA transcripts and was able to discriminate between the ESBL bla OXA and carbapenemases (Brandt et al. 2016) . The same assay also enabled semiquantitative detection of highly expressed insertion sequences associated with MGEs (Brandt et al. 2016) .
These pull-down/enrichment techniques may be advantageous for use in beef cattle research due to their ability to overcome sequencing inhibitors and concentrate genes of interest in the presence of high levels of contaminating bovine DNA. Furthermore, their ability to reduce sequencing costs may make it more palatable to use metagenomics in large-scale AMR surveillance programs. To be successfully applied to beef AMR research, probes will need to be designed, which target ARGs common to agricultural settings, information currently limited in AMR databases. Enrichment techniques are likely to be more applied in the future as the increased frequency of sequence-based AMR beef research supports the generation of more comprehensive AMR databases.
Functional screening of metagenomics libraries
Functional metagenomics is a tool that utilizes metagenomic data to describe gene function and interactions, or more simply, how those genes in a sample translate into protein products. The functional analysis of a gene involves the construction and screening of extracted DNA gene cloning libraries that are expressed in a heterologous host to enable phenotypic screening. This metagenome-wide approach is higher throughput than traditional methods that clone individual genes from single isolates.
Functional metagenomics can be used to examine AMR phenotypes conferred by previously uncharacterized genomic material. For this technique, amplified or native metagenomic DNA fragments from microbial communities are cloned into plasmids (inserts of <10 kb), fosmids (25-45 kb), cosmids (15-40 kb), or bacterial artificial chromosomes (100-200 kb inserts), and expressed in a suitable host such as E. coli. Transformants are screened using phenotypic assays to determine whether an AMR phenotype is conferred by expression products (Ekkers et al. 2012) . Once clones expressing a phenotype of interest are isolated, the genes responsible can be identified via NGS and in silico searches against ARG databases. If homology searches are inconclusive, knockout mutagenesis or subcloning can be employed to determine which gene within the DNA fragment is responsible for the AMR phenotype. Thus, functional metagenomics can facilitate the discovery of novel ARGs within the resistome (Fouhy et al. 2015) .
Although functional metagenomic libraries provide a convenient method to screen for ARGs, they are influenced by the relative abundance of members within the microbial community, and it is possible to miss rare members that contribute a miniscule amount of DNA to library preparation. In addition, some ARGs may not express properly in heterologous hosts due to codon preference, preventing their identification (Fouhy et al. 2015) . For example, although E. coli can support the expression of genes from several donor genomes, an unknown quantity cannot be expressed due to differential transcriptional, translational, or post-translational controls (Uchiyama and Miyazaki 2009) . These may include barriers to promoter recognition and initiation factors, codon usage or ribosomal entry, and protein folding. Using in silico detection of compatible expression signals, it was estimated that roughly 40% of genes within a subset of 32 taxonomically diverse genomes could be expressed in E. coli with a wide range (7%-73%) in expression among genomes (Gabor et al. 2004) . Ralstonia metallidurans has also been shown to be a suitable gram-negative host for the heterologous expression of genes (Craig et al. 2010; Iqbal et al. 2014) . Others have designed plasmid-based shuttle vectors to transfer genes from metagenomic libraries into gram-positive bacteria such as Bacillus subtilis (Troeschel et al. 2012) . Metagenomic libraries have also been used to identify ARGs in unique samples. For example, using fosmid libraries, 1093 AMR-associated genes were detected in human gut microbial communities (Hu et al. 2013) . Elsewhere, using functional genomics, clinical-level resistance to aminoglycosides, tetracycline, and β-lactams was identified in 5000 year-old microbial communities from ancient permafrost soil collected from the Canadian Arctic (Perron et al. 2015) .
Despite not yet being widely employed in beef research, functional screening of metagenomics libraries is likely to be used to identify novel ARGs in samples from beef cattle and their surrounding environment, thereby supporting the development of AMR databases that are more reflective of the production environment. It is also likely that functional metagenomics will be used to identify novel antimicrobials produced by microorganisms in these settings or to facilitate the identification of probiotics that may be employed in these agricultural settings to offset AMU.
Single-cell sequencing
Single-cell sequencing is the study of the individuality of cells using omics techniques (Linnarsson and Teichmann 2016) . As improvements in NGS have reduced the amount of template DNA required for sequencing, it has become feasible to sequence the genome of single cells (Navin et al. 2011) or apply RNAseq to measure single-cell gene expression. Thus, the genome, epigenome, and transcriptome of unculturable or rare microbes can be sequenced (Blainey 2013) . Technical details of bacterial single-cell genome sequencing are reviewed elsewhere (Blainey 2013) . In brief, individual bacterial cells are isolated from complex microbial communities on the basis of phenotypic characteristics such as cell size, shape, or the spectral pattern of native or applied fluorophores. Cells are typically isolated using flow cytometry/cell sorting, laser capture, or microfluidic devices (Wallner et al. 1997 ). The genomic DNA or RNA of the individual cell is then amplified, often via multiple displacement amplification (Raghunathan et al. 2005 ) and sequenced.
Typically, clinical research outpaces veterinary when it comes to the application of novel or newly developed sequencing technologies. As such, single-cell genomics has not yet been utilized in beef AMR research. However, this technique could overcome the limitations of metagenomic approaches in terms of directly linking bacterial species to ARGs or be employed to examine phenomenon such as adaptive resistance in microbial populations from livestock. If coupled successfully with hybridization-based labelling technologies, single-cell sequencing could also be used to sort out ARGs containing cells from mixed populations for targeted WGS. As this technology is less mature than some of the other omics technologies, there are current limits imposed by the algorithms designed for analysis of single-cell data (Linnarsson and Teichmann 2016) . However, these are likely to resolve as the technique is applied with increasing frequency across disciplines.
Genomics-Based Resistance Mitigation Strategies for Beef Production
Genomic analyses can be applied in multiple ways to help combat or mitigate AMR in beef production. On a basic level, ARG surveillance may contribute to an understanding of the relationship between AMR and virulence, and provide insight into the epidemiology of ARG expression in pathogenic and commensal bacterial populations, leading to more effective utilization or reduced use of antimicrobials. Omics tools may also be employed to identify new antimicrobials or antimicrobial targets as well as identify potential alternatives to antimicrobials such as vaccines, probiotic bacteria, or bacteriophage. Genomics can also be used to characterize unique features within microbial genomes that can be targeted or exploited to combat the transmission of ARGs such as the application of the rapidly emerging clustered regularly interspaced short palindromic repeats (CRISPR) -Cas gene-editing systems.
Rational antimicrobial design using target gene identification
Traditionally, antimicrobials have been identified via inhibition screening of cultures grown together with fermentation broths or in the presence of organic compounds generated by microbes (Lewis 2013) . More recently, the majority of new antimicrobials are now synthesized analogues based on the core scaffold of existing antimicrobial families, with alterations that often further improve their activity and pharmacokinetic properties (McPhillie et al. 2015) . Despite this, the rapid development of resistance and the high cost of designing, developing, and bringing a new antimicrobial to market have stalled traditional development pipelines. However, genomic approaches provide new opportunities to study and identify novel antimicrobials.
For antimicrobials to be effective, they must target microbial features essential for cell survival, lack a mammalian homologue (to avoid host side effects), and have broad spectrum activity against multiple bacterial species. Typically, such compounds need to target highly conserved cellular components and features that are now easily identified using comparative genomics. This strategy has been applied to Vibrio cholerae (Chawley et al. 2014 
Gene fitness profiling by transposon-insertion sequencing
Mutagenesis-based genomics have also been applied to identify essential genes that can be exploited as drug targets. Transposon-insertion sequencing (TIS) is one such method used for genome-wide interrogation of gene function, essentiality, fitness, and interaction within functional networks. Transposons are DNA polynucleotides capable of inserting and moving from one location to another within genomes (Munoz-Lopez and Garcia-Perez 2010). The insertion of a transposon into a gene coding sequence usually disrupts function and may alter properties of noncoding DNA. Transposoninsertion sequencing comprises several methods, all utilizing saturated transposon libraries which typically consist of a pooled library of individual insertional mutants constructed within the bacterial strain of interest. Thus, combined with massively parallel sequencing, high-throughput insertion site tracking can be used to determine the location of the transposon within the altered gene. Changes in the frequency of insertion can elucidate the gene's function and fitness depending on the condition of interest under which the pooled library was established. Transposon mutagenesis has been used to identify essential genes in different bacterial species (Gerdes et al. 2002; Roemer and Boone 2013) , including Haemophilus influenzae (Akerley et al. 2002) and Streptococcus pneumoniae (Thanassi et al. 2002) .
In the context of AMR, TIS may be utilized to discover novel antimicrobial targets, virulence factors, and genes essential for colonization and pathology of species carrying ARGs within the host. Products of these identified genes can then be used as vaccine antigens or as targets to generate attenuated vaccine strains. Four major types of TIS include transposon sequencing (Tn-seq), insertion sequencing (INseq), high-throughput insertion tracking by deep sequencing (HITS), and transposondirected insertion site sequencing (TraDIS; Barquist et al. 2013; van Opijnen and Camilli 2013) . Transposon sequencing and INseq both use MmeI-flanked himar1 Mariner transposon libraries (Lampe et al. 1999; van Opijnen et al. 2009 ). MmeI is a type IIS endonuclease cleaving outside and to one side of the recognition sequence. In these methods, it creates 16 bp fragments of transposon-flanking genomic DNA, the sequence of which can be used to identify the site of transposon insertion. High-throughput insertion tracking by deep sequencing and TraDIS rely on random shearing of genomic DNA obtained from the transposon libraries. This is followed by adapter attachment and PCR amplification to enrich transposon-adjacent DNA prior to sequencing. Thus, PCR may introduce bias into HITS and TraDIS methods, but advantageously these methods can be applied to any transposon or transposable element. For all methods, transposon mutagenesis may be complicated for bacterial species that are poorly described, difficult to culture, difficult to transform with DNA, or for which genetic transposon-delivery systems have not been developed. Finally, because transposon mutants with fitness defects are not recovered, validation of TIS discoveries requires the construction of targeted deletion mutants.
Although TIS has not been widely applied in beef cattle research, several studies have shown its promise in the identification of new antimicrobials and vaccine candidates. In one study, TraDIS was used to assign genotypes and fitness scores to mini-Tn5 (transposon) mutants of E. coli O157:H7 strain EDL933 via comparison of inoculation/infection library pools and mutants recovered from calf feces 5 d post inoculation (Eckert et al. 2011 ). Many of the mutations that attenuated colonization were mapped to the locus of enterocyte effacement (LEE). This gene complex harbors a type III secretion system (T3SS) and effectors of host colonization, including eae, intimin, tir (translocated intimin receptor), and z1829, (EspK), all known to influence persistence of enterohemorrhagic E. coli in calves (Naylor et al. 2005) . Other attenuated mutants included insertions in enterohemolysin, O-antigen, and aromatic amino acid biosynthesis genes, and an insertion in the catalytic subunit of stx1A Shiga toxin (Eckert et al. 2011) . Thus, TIS identified O157:H7 genes with roles in the intestinal colonization of cattle, including some genes that code for proteins used to develop anti-E. coli O157:H7 cattle vaccines used in the United States and Canada (Smith 2014) . Transposon-directed insertion site sequencing has also been used to assess the identity and relative fitness of mini-Tn5 insertions in Salmonella enterica serovar typhimurium strain ST4/74 in chickens, pigs, and cattle, revealing 1069 unique mutants with attenuation in at least one animal host (Chaudhuri et al. 2013) . These attenuated mutants, refined for use as live vaccines, could help reduce the transmission of these and other common AMR foodborne pathogens.
In another application, essential genes for the human respiratory pathogens S. pneumoniae, H. influenzae, and Moraxella catarrhalis were identified by Tn-seq and compared in silico with the human genome and human commensal microbiome database to exclude genes with potential off-target/disruptive effects (Mobegi et al. 2014) . In total, 249 essential genes were identified, and 67 were targets of 75 Food and Drug Administration approved antimicrobials and 35 independently researched small molecules (Mobegi et al. 2014) . As proof of principle, novel compounds, without prior known antimicrobial activity, were tested for their ability to target the predicted function of four essential genes involved in fatty acid, methionine, vitamin, and isoprenoid biosynthesis. The antimicrobial activity of some of the tested compounds validated two of the four tested targets (Mobegi et al. 2014) . Thus, similar approaches, expanded to other bacterial species, could provide concrete leads for new targets and antimicrobials. Antimicrobial tolerance can also be explored with TIS, for example, a Tn-seq screen of E. coli mutants tolerant to gentamicin identified >100 genes in multiple pathways (Shan et al. 2015) . Thus, TIS might also be used to predict, design, or develop synergistic drug potentiators that expand the usefulness of current antimicrobials.
RNA-seq transcriptomics
RNA-seq is a technology that allows for the quantitative measurement of global gene expression via massively parallel sequencing (RNA-seq) and has dramatically advanced discovery in multiple areas of biology by facilitating the analysis of dynamic transcriptomes in complex regulatory networks, identifying differentially spliced transcripts and fusions, multiple post-transcriptional modifications and single nucleotide polymorphisms (SNPs)/mutations in mRNA (Wilhelm and Landry 2009) . Beyond mRNA, RNA-seq facilitates ribosome profiling and the study of small RNAs (Ozsolak and Milos 2011; Ingolia 2014) . Further advances allow for simultaneous host-pathogen transcriptomics (dual-RNA-seq) (Westermann et al. 2012) . As RNA-seq is based on NGS, it can be applied in any biological context from which sufficient RNA can be isolated. RNA-seq protocols can be modified in many ways to address specific questions, but the typical transcriptomic approach involves isolation of total RNA, conversion to doublestranded cDNA, and ligation of adaptors for NGS sequencing. Given that the bulk of RNA species (>90%) are composed of rRNA, a number of techniques can be used to deplete rRNA or enrich mRNA.
RNA-seq has rapidly become one of the most important "omics" technologies and has proved useful in elucidating bacterial regulatory hierarchies controlling the expression of ARGs ) and identifying genes that are induced upon antimicrobial exposure (Kjos et al. 2016) . RNA-seq has also been applied in research with relevance to cattle and mitigation of AMR. In one study, RNA-seq transcriptomics of lung and bronchial node tissues from cattle challenged with BRD-associated pathogens identified elevated expression of several antimicrobial peptide (AMP) including natural killer (NK) lysins (Chen et al. 2016) . The bovine genome harbors four NK-lysin genes, and upregulation of NK2A and NK2C was observed in most pathogen-challenged animals (Chen et al. 2016) . The NK2C transcript expression was >20-fold in two of the experimentally challenged animals (Chen et al. 2016) . This further demonstrates the importance of these AMPs as synthetic peptides based on the functional components of these gene products exerted antimicrobial effects on P. multocida and M. haemolytica (Chen et al. 2016) . Current therapies for BRD often involve high-frequency antimicrobial usage, and new control strategies could significantly lessen antimicrobial usage and AMR. For example, selective breeding could further increase the diversity and expand the repertoire of the NK-lysin genes (Chen et al. 2016) , or synthetic peptides could replace current antimicrobials.
RNA-seq has also helped understand host determinants of Bacillus Calmette-Guerin vaccination efficacy in cattle later challenged with Mycobacterium bovis (bovine tuberculosis, bTB). RNA-seq transcriptomics of peripheral blood mononuclear cells harvested from cattle (vaccine protected, vaccine unprotected, and nonvaccinated) showed that upregulation of the gene encoding the host cytokine IL-22 was the dominant predictor of vaccine protection (Bhuju et al. 2012) . Thus, such information could aid in the design and development of a new bTB vaccine. Beyond bTB, RNA-seq could likewise assist in the development of effective vaccines for other bovine pathogens that are currently treated with antimicrobials.
Genomic identification of vaccine targets
Vaccines are the most effective and efficient way to prevent bacterial infection and are a primary means to overcome the current reliance of antimicrobials to treat diseases in beef production. Vaccines are advantageous in that they are an efficient, cost-effective, and sustainable method of disease prevention. Conventional vaccine design relies on the use of heatkilled, live modified, or purified component vaccines typically derived from culturable bacteria. In silico identification of antigen candidates offers some advantages over less specific conventional vaccine development methods. For example, in vitro cultivation of the target organism is not required, eliminating the effects of variable growth expression or antigenic profiles under different growth conditions. In addition, comparative genomics of unrelated pathogens that comprise infectious complexes or commensal populations can identify targets for the development of polyvalent vaccines that are effective against more than one species, or those that are specific to the infection (Seib et al. 2012) . Following identification, antigen candidates used in subunit vaccines are projected to produce a product for clinical trials within 1-2 years vs. 5-15 years commonly required by conventional vaccine development methods (Johri et al. 2006) .
Genomics-based reverse vaccinology successfully identified pathogen-specific surface-exposed vaccine candidates for Neisseria meningitids (Pizza et al. 2000) , Bacillus anthracis (Ariel et al. 2002) , S. pneumoniae (Wizemann et al. 2001) , and Helicobacter pylori (Dutta et al. 2006) . Similarly, comparisons of eight Group B Streptococcus strains identified 312 surface protein vaccine candidates, and a combined vaccine of four of these proteins was protective in a murine disease model (Maione et al. 2005) . Comparative analyses of pathogenic and commensal E. coli revealed pathogen-specific genes encoding proteins that could be targeted to generate pathogenspecific vaccines (Bhagwat and Bhagwat 2008; Rasko et al. 2008) . Likewise, DNA microarrays that compared genomic DNA from M. tuberculosis and M. bovis identified 910 M. tuberculosis-specific open reading frames that were absent in M. bovis (Behr et al. 1999 ). The authors suggested that these missing regions in M. bovis might impair the ability of the BCG vaccine to stimulate a protective immune response against TB. Thus, genomic tools can be used not only to design vaccines but also to evaluate the efficacy of existing formulations, potentially highlighting ways to improve the efficacy of current products.
Vaccination is currently the most effective strategy toward disease management and indirect prevention of AMR in intensive agricultural systems. Vaccines are commonly used in cattle production to reduce the incidence of respiratory infections by viral and bacterial agents. However, the efficacy of many products is limited due to the number of agents involved in diseases complexes (e.g., BRD), lack of universal protection against all serotypes, and challenges faced with eliciting strong immune responses. The continued accumulation of WGS data, coupled with advancement in the bioinformatics tools used to identify conserved surface-exposed or secreted antigens (Petersen et al. 2011 ) and predict bovine immune responses (Lundegaard et al. 2008) , will likely help to alleviate some of these issues and improve the efficacy of future vaccines.
Probiotic identification and validation
According to the World Health Organization, probiotics are defined as live microorganisms which when administered in adequate amounts, confer a health benefit to the host. Probiotics are used in beef cattle with the intention to increase feed efficiency, promote weight gain, support overall health, and reduce the shedding of human pathogens such as E. coli O157:H7 (Chaucheyras-Durand and Durand 2010). For example, the feeding of live yeast to cattle has been shown to improve growth (Lesmeister et al. 2004 ) by increasing the density of cellulolytic microorganisms (Newbold et al. 1996; Mosoni et al. 2007 ). These additives can also stabilize ruminal pH and thereby decrease the risk of acidosis (Chaucheyras-Durand et al. 2008) . Further, the use of Lactobacillus acidophilus in feed has been shown to reduce the shedding of E. coli O157:H7 (Younts-Dahl et al. 2005; Chaucheyras-Durand et al. 2006) and Salmonella enterica (Stephens et al. 2007) . Field studies have shown that these probiotics can reduce E. coli O157:H7 shedding by up to 50% (Brashears et al. 2003) and its presence on hides by as much as 75% (YountsDahl et al. 2005; Stephens et al. 2007) . A reduction in the release of these pathogens into the environment theoretically reduces the risk of humans acquiring infection (Chaucheyras-Durand and Durand 2010). The use of probiotics in livestock may also enhance immune function through the promotion of immunoglobulin production (Musa et al. 2009 ).
Given the above, probiotics are potential alternatives to the use of antimicrobials in beef production, not only as a means to offset the use of growth promoters but also to reduce the carriage of bacterial pathogens that might otherwise prompt AMU. There are multiple avenues whereby genomics could aid in the development of effective probiotics. For example, probiotics can be selected based on functional genomics so that they provide nutrients that limit existing beneficial commensal bacterial species or generate antagonisms that prevent the establishment of pathogens (Callaway et al. 2008) . Whole-genome sequencing of probiotic isolates provides information that aids in the elucidation of how they may contribute to the microbial community (Kullen and Klaenhammer 2000) . This can include identifying key genes or features that limit undesirable bacteria through competition for nutrients and physical attachment sites within the intestinal tract. Other factors could include enhancement of host immune activity (Callaway et al. 2008) . Metagenomics can aid in examining the effects of probiotics strains on the composition of microbial communities as well examine the ability of probiotic strains to establish and persist within microbiomes. Transcriptomics of mRNA from the host as well as from microbiome can be used to identify synergistic relationship between the animal and its microflora. Lastly, functional screening of metagenomic libraries for gene products or metabolites with effective antimicrobial activity may also help to identify prebiotics or important processes in probiotic bacteria. Although genomic tools have not been widely applied to probiotics used in beef cattle production, they have potential to improve the efficacy of these potential alternatives to antimicrobials.
Bacteriophage therapy
Bacteriophages are viruses that specifically infect bacterial hosts. They are divided into two classes: lytic and temperate. Lytic bacteriophages are bactericidal and exploit host molecular machinery to propagate new bacteriophage particles that lyse the host cell, releasing viral progeny into the environment. Temperate bacteriophages integrate into the host bacterial chromosome or may replicate extrachromosomally within an infected bacterial cell. The genome of temperate bacteriophage is passed to daughter bacterial cells during cell division. Of the two forms, lytic bacteriophages have the potential to be exploited as tools to target and kill specific bacteria (Pires et al. 2015) . The efficacy of bacteriophage therapy has been reported against many bacterial pathogens, including MDR P. aeruginosa (Khairnar et al. 2013; Pires et al. 2015) , M. tuberculosis (Hatfull 2010) , and methicillinresistant S. aureus (Takemura- Uchiyama et al. 2014) . Bacteriophage therapy has also been shown to be effective in vivo, reducing Salmonella Typhimurium and Campylobacter jejuni colonization in chickens (Loc Carrillo et al. 2005; Atterbury et al. 2007; Waseh et al. 2010) and Salmonella and E. coli O157:H7 in cattle (Johnson et al. 2008) .
In addition to the targeted bactericidal effects of lytic bacteriophage, engineered phage may also be used to deliver targeted genes to favorably alter bacterial populations (Karimi et al. 2016) . This method has been used to deliver DNA encoding bactericidal proteins in an E. coli model (Westwater et al. 2003) . It has also been used to transform a streptomycin-resistant E. coli with a plasmid that contained a copy of the wild-type susceptibility gene rpsL, rendering the resistant strain ∼10-fold more sensitive to this antimicrobial (Edgar et al. 2012) . The potential for engineered bacteriophage to deliver targeted antimicrobials to specific bacterial populations may reduce the total volume of antimicrobials required to for therapy, thereby reducing AMU.
In addition to bacteriophage strategies, phage-derived proteins called endolysins possess antimicrobial activity, and in conjunction with other phage proteins (e.g., holins) can degrade the bacterial cell membrane and peptidoglycan layer. Endolysins lyse gram-positive bacterial cell walls when applied extracellularly (Loessner 2005) with the recombinant Ply511 endolysin from Listeria monocytogenes phage A511 being active against MRSA (Turner et al. 2007 ). Other endolysins have also been used successfully against Streptococci in vitro (Nelson et al. 2001 ) and against S. pneumoniae, S. agalactiae, S. pyogenes, and B. anthracis in animal disease models (Schmelcher and Loessner 2016) . Contradicting previous dogma, the antimicrobial activity of bacteriophage proteins is not limited to gram-positive bacteria as a recombinant phage carbohydrate-binding protein (Gp047) from the C. jejuni phage NCTC 12673 was active against C. jejuni NCTC 11168 (Javed et al. 2015) . In additional, the lysin, PlyF307 present in bacteriophage induced from Acinetobacter baumannii strain 2198, was able to kill multiple MDR A. baumannii strains in vitro and reduce mortality in mice challenged with this bacterium (Lood et al. 2015) . The potential to exploit these compounds as antimicrobials in veterinary settings may help alleviate the current lack of novel antimicrobials within pharmaceutical pipelines. It is also important to note that many bacteriophage proteins may also be used to enhance the effectiveness of existing antimicrobials as some, like Pseudomonas putida phage AF proteins can degrade biofilms (Cornelissen et al. 2012) . Although not a true antimicrobial, use of these proteins to reduce the protective effects of biofilms against antimicrobials may help increase the efficacy of antimicrobials that are already used in beef production.
Genomics may aid in the identification of novel lytic bacteriophage for use as therapies in beef production systems through WGS of bacteria or through metagenomic sequencing of viromes collected from both beef cattle and their environment. Sequence analysis of bacteriophage genomes as well as transcriptomic and functional metagenomics may all be employed to help identify viral peptides that can be exploited as antimicrobials or reduce the robustness of biofilms. As more information is gathered about bacteriophage diversity within this environment, this novel mitigation method may prove useful for the control and eradication of MDR pathogens in beef production systems.
Biofilm inhibition and dispersal
Bacteria grown in vitro typically display planktonic growth that maximizes their susceptibility to antimicrobial agents. However, within natural environments, bacteria often form complex communities that are densely integrated into a biofilm bound by extracellular polymeric substances. Biofilm bacteria have increased resistance to antimicrobials agents, due to exclusion of the antimicrobial, slow bacterial growth rates that impede antimicrobial activity and expression of secreted antimicrobial degrading products by some bacterial species within the community (Gabrani et al. 2015) . Therapeutic doses of antimicrobials that are based on susceptibility levels obtained in vitro may not be effective against microbes encased within biofilms, resulting in treatment failure.
Inhibition and (or) dispersal of microbial biofilms could lead to improved antimicrobial efficacy. Genomic technologies augment biofilm research via improved understanding of biofilm complexity and community composition (Sauer 2000) , and can assist in the identification of therapeutic agents that degrade (Gökçen et al. 2014) or inhibit the formation of biofilms. One strategy to mitigate biofilms has been to utilize antibodies raised against sequence-identified proteins involved in biofilm formation. These include the accumulation-associated protein produced by S. epidermidis (Sun et al. 2005 ) and the P. aeruginosa biofilm protein PsI (DiGiandomenico et al. 2012) . Additional sequencing may identify more of these target proteins in biofilm-producing species. Wild type and engineered bacteriophages have also been used as a tool to effectively disperse P. aeruginosa and E. coli biofilms through their bactericidal effects (Alemayehu et al. 2012) . Using genomics tools to identify more targets for bacteriophage-induced biofilm dispersal will maximize the utility of such strategies. At last, there are many proteins that have been shown to have antibiofilm activity including DNase I/DNase 1L2 (Eckhart et al. 2007 ), human antimicrobial peptide cathelicidin LL-37, and some synthetic peptides (Overhage et al. 2008; Dean et al. 2011) . Thus, functional genomics can be applied to environmental samples to identify molecules that can degrade or disperse biofilms, resulting in products that could reduce AMU through improved antimicrobial efficacy.
Antimicrobial peptides
Antimicrobial peptides (AMPs) are short positively charged amphipathic peptides, produced by many organisms that play a role in innate immunity (Boman 1995) . These peptides bind to and neutralize negatively charged cell surfaces (lipoteichoic acid and lipopolysaccharide) of a wide range of gram-positive and gramnegative bacteria, mainly through perturbations in the cell envelope (Jenssen et al. 2006) . Antimicrobial peptides have also been shown to traverse the cell membrane and interact with DNA or DNA polymerase to effect cell death (Powers and Hancock 2003) . Bacteriocins are a class of AMP produced by numerous bacterial species (Galvez et al. 2008) , some of which share homology with bacteriophage genes, suggesting a possible common origin. Bacteriocins kill bacteria by a number of mechanisms. For example, R-type pyocins form pores in the bacterial membrane whereas a novel pyocin from P. aeruginosa JJ692 hydrolyzed peptidoglycan (Scholl and Martin 2008; Barreteau et al. 2009 ). As these AMPs are produced in a wide array of bacteria, WGS and comparative genomics can be used to screen microbial genomes for novel bacteriocins that could be used as antimicrobials.
In addition to bacterial sources, AMPs can also be produced by mammalian hosts as a first line defence against microbial pathogens. An example of this is a cysteinerich AMP formed in the tracheal mucosa of cattle, named tracheal antimicrobial peptide (TAP). This defensin displays broad-spectrum activity against respiratory pathogens in vivo (Yarus et al. 1996) . Sequence analysis of the coding region of the TAP gene identified a nonsynonymous SNP that corresponded to varied bactericidal activity of the peptide (Taha-Abdelaziz et al. 2013 ). This finding highlighted the important role genomic tools have in providing a mechanistic understanding of the function of AMPs. The design and synthesis of potent antimicrobial peptides may offer a valuable alternative to antimicrobials.
CRISPR-Cas gene editing
The CRISPR-Cas9 system is a technology that is increasingly exploited for genome editing, and has recently been successfully used to target and eliminate populations of AMR bacteria. CRISPR-Cas systems are used by bacteria to resist invasion by foreign nucleic acids, which include bacteriophage genomes and plasmids (Makarova et al. 2011) . They are genomic features that carry repetitive sequences interspersed with short spacer segments. The spacers are complementary to the foreign nucleic acids from which they were derived. CRISPR-associated (Cas) genes encode proteins with nuclease (e.g., Cas9) or helicase activity. Mechanistically, in the case of CRISPR-Cas9, the spacer DNA nucleotide sequence is transcribed into crRNA, which guides the Cas9 nuclease to the re-infecting foreign DNA, which is then degraded (Marraffini and Sontheimer 2010) .
Self-targeting CRISPR-Cas are cytotoxic and were originally proposed by Marraffini and Sontheimer (2008) as a means of limiting the spread of AMR in pathogenic bacteria. Two groups, Bikard et al. (2014) and Citorik et al. (2014) , applied this idea and engineered plasmids with phage packaging signals, called phagemids, which contained all genetic components necessary for CRISPR-Cas activity in a form that was contained and deliverable by bacteriophage. In both cases, the packaged phagemids were used to target chromosomal material as well as antimicrobial-resistant plasmids, leading to successful plasmid removal from the bacterial population. In the study by Bikard et al. (2014) , an antiaph CRISPR-Cas construct rendered S. aureus cells immune to future acquisition of the aph gene and its associated kanamycin resistance, providing proof of principal that CRISPR-Cas systems can prevent the spread of plasmid-borne resistance genes. In the study by Citorik et al. (2014) , the phagemid was used to target the chromosomally located DNA gyrase gene conferring resistant to quinolone antimicrobials as well as to simultaneously target two different β-lactamases, encoded by bla NDM-1 and bla , highlighting the versatility of the technology and its potential to target multiple ARGs at once.
The application of CRISPR-Cas systems to mitigate AMR in beef cattle is possible but requires the development of a product that is both effective and economically appealing to producers. Both S. aureus and E. coli are clinically relevant microbes, and the bacteriophages associated with these bacteria have been well characterized. Phage can be highly specific, attaching to surface receptors that are often unique to a particular bacterial species (Drulis-Kawa et al. 2012) . To be able to apply a similar phagemid-based approach to control AMR in beef production, more information will be required about the specific bacterial species/strains that contribute to the ARG reservoir along with their associated bacteriophage. Conjugation has been examined as an alternative delivery route for CRISPR-Cas systems, but transfer efficiencies were too low for effective application (Citorik et al. 2014) . However, further research into the use of conjugation-based delivery of CRISPR-Cas systems could yield a less discriminant and more widely applicable product than phage delivery-based approaches. Regardless of the route to development, the application of a well-designed CRISPR-Cas-based system holds the potential for AMR mitigation in the feedlot environment and will likely be a subject of future investigation.
Conclusion
As the global demand for animal protein continues to increase, so does the drive toward more intensive agriculture that currently relies on AMU to control infectious diseases. Maintaining the efficacy of antimicrobials as a resource in beef production is of critical importance. Genomic technologies have already yielded significant advancements in our understanding of the transmission of AMR human pathogens, the development of novel antimicrobials, and the development of novel AMR mitigation strategies. Future efforts to combat AMR via effective surveillance in human and animal health settings, vaccine development, and the identification and formulation of alternatives to antimicrobials will rely heavily on genomic approaches. Taken together, these efforts may help minimize AMU and the impact of AMR bacteria and the infectious diseases they cause on beef cattle production.
